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Abstract
Re‐expansion Pulmonary Edema (REPE) is a recognized but rare complication of lung
re‐inflation after pathologic collapse or intentional deflation. The presentation of
REPE may be highly variable, ranging from a clinically asymptomatic, incidental
radiologic finding to acute respiratory failure accompanied by severe, life‐threatening
hypoxemia. With the current report, we present a patient with severe aortic
insufficiency, severe mitral regurgitation, coronary artery disease, pulmonary
hypertension, who underwent aortic valve replacement, mitral valvuloplasty,
coronary artery bypass grafting, and developed at the immediate post‐ operative
period severe respiratory failure due to REPE, requiring venous‐venous Extracorpor-
eal Membrane Oxygenation (VV‐ECMO).
1 | PATIENT PROFILE
A 62‐year‐old male with a history of congestive heart failure (New
York Heart Association class IV) presented with shortness of breath
and exercise intolerance due to severe aortic and mitral insuffi-
ciency, coronary artery disease, and pulmonary hypertension. He
had a 6‐month history of recurrent bilateral pleural effusions.
Additionally, his past medical history was significant for hyperlipi-
demia, hypertension, gastroesophageal reflux disease, transient
ischemic attack and reported a significant smoking history having
quit 2 years before presentation. Preoperative transesophageal
echocardiography (TEE) indicated right coronary territory wall
motion abnormalities, severe aortic insufficiency with eccentric jet,
mild tricuspid regurgitation, severe mitral regurgitation with central
jet and poor coaptation due to annular dilation and normal leaflets
(Carpentier type I mitral valve dysfunction). Pulmonary hyperten-
sion and depressed ejection fraction (50%) were also noted. A left
heart catheterization showed a mid‐right coronary lesion at 70%
stenosis. A right heart catheterization revealed elevated pulmonary
artery pressures (PAP) (64/25 mm Hg) and elevated pulmonary
capillary wedge mean pressure of 27 mm Hg. The patient
deteriorated on guideline‐directed medical therapy. Although high
risk, double valve and coronary artery bypass surgery were offered
to the patient and he consented.
An intraoperative TEE confirmed the preoperative findings. A
diastolic arrest was achieved with augmented retrograde blood
cardioplegia given at 10‐minute intervals. The right coronary artery
was bypassed with reversed saphenous vein graft. Exposure of the
mitral valve through the interatrial grove permitted mitral valve
repair with a 31mm Duran AnCore annuloplasty ring (Medtronic, St
Paul, MN). Aortic valve replacement used a 23mm Inspiris®
pericardial tissue valve (Edwards Life Science, Irvine, CA). Before
separating from cardiopulmonary bypass, 3 L of serous pleural
effusion was drained from the pleural spaces. Cessation of
cardiopulmonary bypass was achieved with adequate oxygenation
and ventilation on inotropic and vasopressor support with milrinone
(0.375mcg/kg/minutes), norepinephrine (6mcg/min), and vasopres-
sin (0.04 units/minutes).
The patient received 1000mL of crystalloids, 500mL of colloids,
and 350mL of cell‐saver blood. Excellent urine output ensued, and no
blood products were administered. Postoperative PAP was 35/16 mm
Hg. While preparing to transport the patient to the critical care unit,
oxygen desaturation occurred associated with frothy fluid in the
endotracheal tubing. Management included adjustments in ventilatory
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support, diuretics, and a bronchoscopy was performed revealing
normal airways but a significant amount of serous fluid. Intraoperative
TEE revealed normal aortic prosthesis function, no residual mitral
valve regurgitation, no tricuspid regurgitation and confirmed no wall
motion abnormalities and the pre‐operative ejection fraction (~50%).
An intraoperative chest radiograph showed only expected post-
operative findings (see Figure 1). His condition precipitously deterio-
rated on transfer to the intensive care unit. Severe pulmonary edema
developed with voluminous clear, frothy fluid present in the
endotracheal tubing. Pulmonary compliance worsened (peak airway
pressures exceeded 70mm Hg), with severe hypoxemia (paO2 was
45mm Hg on 100% FiO2 and on positive end‐expiratory pressure
(PEEP) of 12 cm H2O). Initiation of inhaled nitric oxide and intravenous
diuretics produced no improvement in oxygenation. Repeat TEE
confirmed stable left and right ventricular function, normal prosthetic
aortic valve performance, no mitral regurgitation, no systolic anterior
motion or left ventricular outflow obstruction and a normal mitral
valve gradient. Non‐cardiogenic pulmonary edema of unknown
etiology could not be conclusively eliminated as a possible diagnosis.
Because maximal efforts at resuscitation with conventional ventila-
tory support (including volume controlled and pressure controlled
mechanical ventilation, increased PEEP and FiO2) did not result in
improvement, emergent Veno‐Venous extracorporeal membrane oxyge-
nation (V‐V ECMO) was instituted at the bedside. An Avalon Elite Bi‐
Caval Catheter (Getinge, Wayne, NJ) was used placed through the right
internal jugular vein, under fluoroscopic and TEE guidance (see Figure 2).
V‐V ECMO achieved adequate flows and oxygenation improved shortly
afterwards. Metabolic derangements were corrected, and throughout the
next 36 hours, inotropic agents and vasopressors were weaned. V‐V
ECMO was removed on postoperative day 3. On postoperative day 4
positive pressure ventilation was discontinued. On postoperative day 10,
the patient was discharged from the hospital in satisfactory condition.
The patient currently remains asymptomatic after 3 years of follow‐up
with no pulmonary sequela.
2 | DISCUSSION
Re‐expansion pulmonary edema (REPE) is a rare but well‐known entity.
However, to our knowledge, it has not been described following
conventional (sternotomy) cardiac surgery without associated blood
transfusions. REPE was first reported in the mid‐1800s and is most
commonly seen following large volume thoracentesis.1–3 Suggested risk
factors for the development of REPE include; age between 20 and 40
years old, diabetes, duration of lung collapse, high negative pressures
following drainage (more negative than ‐ 20 cmH2O), and draining
greater than 1.5 L of fluid.4,5 Feller‐Kopman et al2 found in their
retrospective review of 185 patients that REPE did not correlate with the
amount of fluid withdrawn from the chest. Postoperative unilateral
pulmonary edema, often subclinical, occurs in up to 25% of patients
undergoing minimally invasive cardiac surgery for which one‐lung
ventilation is used for prolonged periods.6 Risk factors include Chronic
Obstructive Pulmonary Disease (COPD), pulmonary hypertension, right
ventricular dysfunction, and increased CPB time. A report of REPE
following conventional (sternotomy) coronary bypass surgery described
an association with transfusion of fresh frozen plasma, which was not a
factor in our case.7 Draining pleural effusions is a common practice during
cardiac surgery. Our patientʼs effusions were large (3 liters) and chronic
(more than 4 months). In addition, the CPB time was prolonged. Systemic
Inflammatory Response Syndrome (SIRS) occurring after cardiac surgery
under cardiopulmonary bypass is due to surgical trauma, contact of blood
with foreign materials, abnormal sear stress, ischemia‐reperfusion,
hypothermia, and lack of homeostasis. Severe inflammatory response to
CPB was included in our differential diagnosis which in association with
F IGURE 1 Shows the initial intraoperative chest X‐ray after
encountering difficulty with oxygenation and following
F IGURE 2 shows the degree of pulmonary edema accrued after
only 2 to 4 hours following the initial postoperative chest‐XR. Note
the Avalon Elite Bi‐Caval Catheter extending to the right atrium
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ischemia‐reperfusion injury (from lung collapse during CPB) may produce
a similar clinical manifestation with REPE.
The pathophysiologic mechanism of REPE has been extensively
studied and is likely multifactorial. Ischemia‐reperfusion injury and
increased vascular permeability from activation of the proinflammatory
cascade (mediated by IL‐8 and leukotriene B4), subsequent neutrophilic
and macrophage invasion, surfactant dysfunction, and hyaline membrane
formation all play roles in its pathogenesis. Sohara suggests that chronic
lung collapse leads to abnormally hardened pulmonary microvessels. The
mechanical stress of re‐expansion and alveolar recruitment then
produces REPE. Lung injury caused by ischemic‐reperfusion results in
free radical damage and leukocyte sequestration.8 Compared to two‐lung
ventilation controls, the duration of one‐lung ventilation for greater than
120 to 180minutes shows a significant increase in the production of
reactive oxidative species.8 Lung injury in this setting is accentuated by
poor perfusion secondary to shunted blood flow to the contralateral lung.
It is postulated, in our case, that the combination of chronic congestive
heart failure, large bilateral chronic pleural effusions leading to
parenchymal collapse, followed by prolonged CPB initiated REPE. Rapid
recognition of this life‐threatening refractory respiratory insufficiency led
to the institution of V‐V ECMO, which might have intensified the severity
of SIRS. Our patient's oxygenation improved on V‐V ECMO and he
recovered from what would have been a fatal postoperative outcome.
Based on our experience, preoperative drainage of chronic large pleural
effusions as a part of medical optimization for complex cardiac surgery, as
well as, intraoperative periodic lung inflation/deflation during CPB should
be a consideration.
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